Ring One Gen 2: Why caution is advised for more than blood pressure claims

First off: We are neither alleging fraud nor making outright accusations at this stage, but we strongly advise the utmost caution regarding the ongoing crowdfunding campaign for the Ring One Gen 2. In fact, we would explicitly warn readers against backing this project—even at the entry tier of $209. There are several reasons for our skepticism. The technical red flags are the most obvious. The Ring One 2.0 is claimed to directly measure blood pressure at the finger—rather than merely estimating it—and to do so without any prior calibration. While optical blood pressure tracking concepts do exist, such a major technological breakthrough by a relatively small company seems highly improbable. Compounding the issue, the campaign's FAQ page makes no mention of blood pressure measurement whatsoever, presenting a glaring inconsistency. On the other hand, standard features like optical heart rate monitoring and NFC payments are entirely feasible in this form factor.

The company's behavior on Indiegogo is equally perplexing. Indiegogo allows non-backers to post comments, a space typically used for critical inquiries. However, Muse appears to be using this feature to flood the section with posts from employees detailing how exciting it was to work on the product. By upvoting these posts, the company effectively buries critical user feedback in both the chronological and top-comment views. Even so, a few users continue to defend Muse in the discussion threads. Meanwhile, first-generation backers were reportedly promised a free upgrade to the Ring One 2.0—though according to one user report, it actually comes with a $149 fee. What remains undisputed is that shipping for the original Ring One suffered severe delays, with some backers claiming they never received their devices at all. Muse now points to a new "Production Dashboard" intended to prove that operations will run smoothly this time around.